00000nam 2200000za 4500 9.847576 CaOODSP 20221107153455 cr ||||||||||| 171122s2018 onc o f000 0 eng d 9780660239583 9780660239590 CaOODSP eng n-cn--- NR16-174/2017E-PDF National Research Council Canada. Peptides against cancer (L-11627/11964) [electronic resource]. [Ottawa] : National Research Council Canada, [2018] [1] p. Issued also in French under title: Peptides contre le cancer (L-11627/11964). Caption title. "December 2017." “NRC has developed peptides with novel anti-angiogenic properties that are effective against many different stimulators of angiogenesis. The NRC peptides exhibit direct anti-tumorogenic properties against different types of tumors and have been validated in vivo. The antiangiogenic activity against multiple stimulators, combined with the direct inhibition of tumour growth, position these peptides as promising treatments against malignant tumours”--Highlights. Issued also in print format. Neovascularization inhibitors Peptides Peptides contre le cancer (L-11627/11964) (CaOODSP)9.847578 HHT peptides against cancer (CaOODSP)9.847577 PDF 152 KB https://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-174-2017-eng.pdf